Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for AVTR given its capital-intensive manufacturing and distribution model, significant goodwill balances, and debt-funded capital structure.

Composite Trajectory: Deteriorating

Revenue has declined organically for three consecutive fiscal years (FY2023–FY2025) and in the first half of 2026, while gross margin has compressed in every comparable period presented. GAAP operating income swung from $1.08 billion in FY2024 to a $246 million loss in FY2025 due to a $785 million goodwill impairment, and net income fell from $711.5 million to a $530.2 million loss. In the first half of 2026, operating income fell 19.9% year-over-year and net income fell 37.0% despite flat reported revenue. Operating cash flow has declined for three straight fiscal years and dropped 10.2% in the first half of 2026 versus the prior year. Free cash flow fell 35.5% in FY2025 and 19.0% in the first half of 2026. The balance sheet shows deleveraging but at the cost of a major goodwill write-down, declining cash reserves, and a VWR Distribution reporting unit whose fair value exceeds carrying value by only 5.5% as of March 2026.

2. Red Flags

• Goodwill impairment and ongoing risk: A $785.0 million non-cash goodwill impairment was recorded in Q3 2025 for the Distribution reporting unit; as of March 31, 2026, the VWR Distribution reporting unit’s fair value exceeded carrying value by only approximately 5.5%, with $2.8 billion of goodwill allocated to it (10-K 2025, Critical accounting policies; 10-Q 2026-03-31, Note 7; 10-Q 2026-06-30, Note 7).
• Persistent organic revenue decline: FY2025 organic net sales fell 2.8% ($188.2 million); Q1 2026 organic net sales fell 4.1% ($64.3 million); Q2 2026 organic net sales fell 0.4% ($6.8 million); H1 2026 organic net sales fell 2.2% ($71.1 million) (10-K 2025, Results of operations; 10-Q 2026-03-31, Net Sales; 10-Q 2026-06-30, Net Sales).
• Gross margin compression in every period: FY2025 gross margin declined 90 bps to 32.7%; Q1 2026 gross margin fell 210 bps to 31.7%; Q2 2026 gross margin fell 120 bps to 31.7%; H1 2026 gross margin fell 170 bps to 31.7% (10-K 2025, Gross margin; 10-Q 2026-03-31, Gross margin; 10-Q 2026-06-30, Gross margin).
• Declining operating cash flow for three consecutive fiscal years: $870 million (FY2023) → $840.8 million (FY2024) → $623.8 million (FY2025); H1 2026 operating cash flow fell to $236.9 million from $263.7 million in H1 2025 (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows).
• Free cash flow declining sharply: FY2025 free cash flow $496.4 million vs $768.3 million in FY2024 (-35.5%); H1 2026 free cash flow $168.0 million vs $207.5 million in H1 2025 (-19.0%) (10-K 2025, Free cash flow; 10-Q 2026-06-30, Free cash flow).
• Rising effective tax rate: H1 2026 effective tax rate 40.5% vs 22.8% in H1 2025; Q2 2026 effective tax rate 53.1% vs 20.8% in Q2 2025, attributed to a change in estimate of uncertain tax positions (10-Q 2026-06-30, Note 13).
• Securities class action litigation: Two putative securities class actions filed in Q4 2025, consolidated in Delaware, with motion to dismiss filed July 2026; outcome unpredictable and potential loss not estimable (10-Q 2026-06-30, Note 8).
• Share repurchases amid declining cash generation: $75 million repurchased in November 2025 with $425 million remaining authorized while free cash flow fell 35.5% in FY2025 and 19.0% in H1 2026 (10-K 2025, Liquidity; 10-Q 2026-06-30, Liquidity).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

GAAP revenue has declined in each of the last three fiscal years ($6,967.2 million → $6,783.6 million → $6,552.2 million) and organic net sales have fallen in every quarterly and year-to-date period presented in 2026. Gross profit has fallen correspondingly ($2,363.8 million → $2,279.3 million → $2,139.4 million annually; $1,089.0 million → $1,037.7 million in H1 2026). Gross margin has compressed in every comparable period: FY2025 -90 bps, Q1 2026 -210 bps, Q2 2026 -120 bps, H1 2026 -170 bps. GAAP operating income collapsed from $1,084.8 million in FY2024 to a $246.2 million loss in FY2025, driven by the $785.0 million goodwill impairment and absence of a prior-year gain on sale. In H1 2026, operating income fell 19.9% to $221.3 million from $276.2 million. Net income dropped from $711.5 million to a $530.2 million loss annually, and fell 37.0% to $81.4 million in H1 2026 from $129.2 million. Diluted EPS fell from $1.04 in FY2024 to -$0.78 in FY2025, and from $0.19 in H1 2025 to $0.12 in H1 2026.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Net cash provided by operating activities has declined for three consecutive fiscal years: $870 million (FY2023) → $840.8 million (FY2024) → $623.8 million (FY2025), a 25.8% drop in FY2025 alone. In H1 2026, operating cash flow fell 10.2% to $236.9 million from $263.7 million in H1 2025, driven by lower net income and higher working capital requirements. Free cash flow (operating cash flow less capex plus divestiture-related items) fell 35.5% in FY2025 to $496.4 million from $768.3 million, and fell 19.0% in H1 2026 to $168.0 million from $207.5 million. Capital expenditures were relatively stable ($148.8 million in FY2024, $128.8 million in FY2025, $71.1 million in H1 2026 vs $57.6 million in H1 2025). Cash balances declined from $365.4 million at December 31, 2025 to $306.8 million at June 30, 2026 despite $1.1 billion in new term loan proceeds in Q4 2025, as debt repayments of $1.43 billion and $75 million of share repurchases offset inflows.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total debt (gross) decreased from $3,967.9 million at December 31, 2025 to $3,715.4 million at June 30, 2026, reflecting prepayments on Euro term loans. The current portion of debt rose slightly from $30.8 million to $37.0 million. Total liabilities fell from $6,229.7 million to $5,965.7 million. Stockholders’ equity increased modestly from $5,565.0 million to $5,630.2 million, supported by net income of $81.4 million in H1 2026 and a reduction in accumulated other comprehensive loss. However, cash and cash equivalents declined from $365.4 million to $306.8 million. Goodwill decreased from $4,986.9 million to $4,935.4 million (primarily foreign currency translation), following the $785.0 million impairment in 2025. The VWR Distribution reporting unit carries $2.8 billion of goodwill with fair value only 5.5% above carrying value as of March 31, 2026. Accounts receivable rose from $1,074.6 million to $1,138.9 million and inventory from $818.2 million to $828.7 million, while accounts payable were flat at $741.7 million vs $743.2 million. The company states its net leverage ratio is below the 3.75x threshold requiring excess cash flow prepayments.

6. Data Gaps

• Quarterly GAAP results for Q3 2025 and Q4 2025 (only annual FY2025 figures provided in 10-K)
• Full 10-Q for Q2 2025 (six months ended June 30, 2025) – provided text is truncated
• FY2023 quarterly data to assess pre-2024 quarterly trends
• Free cash flow for FY2023 (not reconciled in 10-K)
• Exact net leverage ratio and interest coverage ratio values (only stated as “within covenant requirements”)
• Segment-level balance sheet data (not disclosed to CODM)
• Standalone Q2 2026 cash flow statement (only six-month year-to-date provided)
• Detailed breakdown of “Other” non-cash items in operating cash flow reconciliation
• Quantification of divestiture impact on FY2025 cash flows beyond the $76.3 million transaction expenses/taxes paid